Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell Carcinoma (vol 8, e00281, 2024)

被引:0
|
作者
Hitasha, Kalola P. A.
机构
关键词
D O I
10.1200/PO-24-00733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma
    Correa, Andres F.
    Kalashnikova, Ekaterina
    Wu, Hsin-Ta
    Winters, Ryan M.
    Balcioglu, Mustafa
    Sudhaman, Sumedha
    Connolly, Denise C.
    Gong, Yulan
    Uzzo, Robert G.
    Sethi, Himanshu
    Elnaggar, Adam C.
    Aleshin, Alexey
    Liu, Minetta C.
    Abbosh, Philip H.
    ONCOLOGIST, 2024, 29 (10): : 887 - 893
  • [32] Exploring the Characteristics of Circulating Tumor DNA in Pt1a Clear Cell Renal Cell Carcinoma: A Pilot Study
    Kim, Hongkyung
    Park, Jee Soo
    Choi, Zisun
    Min, Seungki
    Park, Jihyang
    Shin, Saeam
    Choi, Jong Rak
    Lee, Seung-Tae
    Ham, Won Sik
    CANCERS, 2023, 15 (13)
  • [33] Concordance of circulating tumor DNA and imaging surveillance in patients with urothelial carcinoma and renal cell carcinoma post-immunotherapy.
    Meng, Lingbin
    Collier, Katharine A.
    Hasanov, Elshad
    Mortazavi, Amir
    Clinton, Steven K.
    Wang, Peng
    Zimmerman, Danielle Elise
    Bicer, Fuat Bicer
    Gauntner, Timothy D.
    Folefac, Edmund
    Monk, Paul
    Yang, Yuanquan
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [34] DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH RENAL CELL CARCINOMA COMPARED WITH A CONTROL GROUP
    Gutschi, T.
    Pachernegg, O.
    Heidler, S.
    Zigeuner, R.
    Pummer, K.
    Lackner, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 649 - 649
  • [35] Detection of circulating tumor cells in patients with renal cell carcinoma compared with a control group
    Gutschi, T.
    Pachernegg, O.
    Lackner, K.
    Hutterer, G. C.
    Stauber, R.
    Pummer, K.
    Zigeuner, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.
    Pop, Laurentiu
    Stein, Maggie Janell
    Christie, Alana
    Manna, Subrata
    Garant, Aurelie
    Yang, Daniel X.
    Desai, Neil B.
    Brugarolas, James
    Timmerman, Robert D.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 477 - 477
  • [37] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [38] Plasma circulating tumor DNA is scarce and confounded by clonal hematopoiesis in metastatic renal cell carcinoma
    Bacon, Jack V. W.
    Annala, Matti
    Soleimani, Maryam
    Lavoie, Jean-Michel
    So, Alan I.
    Gleave, Martin E.
    Fazli, Ladan
    Chi, Kim N.
    Kollmannsberger, Christian K.
    Wyatt, Alexander W.
    Nappi, Lucia
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 43 - 43
  • [39] Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma.
    Kotecha, Ritesh
    Gedvilaite, Erika
    Murray, Samuel J.
    Motzer, Robert J.
    Tsui, Dana
    Voss, Martin Henner
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus
    Whitson, Jared M.
    Reese, Adam C.
    Meng, Maxwell V.
    BJU INTERNATIONAL, 2011, 107 (05) : 729 - 734